ZELDIS JEROME B Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$110,888.96
Insider Sells Quantity
3
Insider Sells Sum
$2M

Insider Activity of ZELDIS JEROME B

Biography of ZELDIS JEROME B

No biography is available at this moment.

2024-12-02SalePTC Therapeutics, Inc.
PTCT
director
24,000
0.0303%
$51.50$1.24M-4.3%
2024-11-20PurchaseNEXGEL, Inc.
NXGL
director
3,636
0.0323%
$2.75$9,999-21.06%
2024-08-23PurchaseNEXGEL, Inc.
NXGL
director
10,000
0.1028%
$2.50$25,000+6.92%
2024-05-22SalePTC Therapeutics, Inc.
PTCT
director
20,000
0.0258%
$38.24$764,800+9.81%
2023-05-26PurchaseNEXGEL, Inc.
NXGL
director
5,000
0.0914%
$2.34$11,689-3.06%
2022-03-25PurchaseNEXGEL, Inc.
NXGL
5,300
0.095%
$1.89$10,010-19.05%
2021-05-14SaleSoligenix, Inc.
SNGX
director
3,000
<0.0001%
$0.90$2,701+1.43%
2021-05-14PurchaseSoligenix, Inc.
SNGX
director
3,000
<0.0001%
$0.89$2,664+1.43%
2019-11-19PurchaseSoligenix, Inc.
SNGX
director
2,000
0.0101%
$0.93$1,850+92.63%
2019-09-19PurchaseSoligenix, Inc.
SNGX
director
4,000
<0.0001%
$0.94$3,740+93.21%
2019-04-22PurchaseSoligenix, Inc.
SNGX
director
10,000
0.0002%
$0.73$7,274+47.89%
2015-12-23PurchaseSoligenix, Inc.
SNGX
director
2,500
<0.0001%
$1.27$3,175-36.84%
2013-06-25PurchaseSoligenix, Inc.
SNGX
director
23,809
0.0009%
$1.05$24,999+109.38%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.